glp-1 news employers Your Weight-Loss Drugs Are Next on the Corporate Chopping Block 2026 Employee Benefits Trends: Should

Studies show that dual GIP/GLP-1 medications can help people effectively lose weight, control blood sugar, and improve heart health

In 8 IL-23i PsA studies there were NO new TB or LTBI reactivations To view or add a comment, sign in The FDA has approved Gilead's bulevirtide (Hepcludex) for chronic hepatitis delta virus (HDV) infection, making it the first and only approved therapy for chronic HDV in the US

Neuroendocrinology 94 , 291301 (2011)

True plateaus occur at stable weight

Liraglutide induced a significant improvement in mechanical allodynia over time compared with the vehicle-treated group (day 14: liraglutide 20 g p = 0.0098, day 28: liraglutide 20 g p = 0.0038, dexamethasone 20 g p = 0.0002, compared to vehicle-treated group)

At doses approved for weight loss, Saxenda is about 50% as effective as Wegovy (semaglutide 2.4 mg SC weekly)